1 |
Friedrich, C., M. G. Scott, N. Karunaratne, H. Yan, and R. E. Hancock. 1999. Salt-resistant alpha-helical cationic antimicrobial peptides. Antimicrob. Agents Chemother. 43: 1542-1548
PUBMED
|
2 |
Shin, S. Y., S. T. Yang, E. J. Park, S. H. Eom, W. K. Song, Y. Kim, K. S. Hahm, and J. I. Kim. 2002. Salt Resistance and Synergistic Effect with Vancomycin of alpha-Helical Antimicrobial Peptide P18. Biochem. Biophys. Res. Commun. 290: 558-562
DOI
ScienceOn
|
3 |
Tomita, T., S. Hitomi, T. Nagase, H. Matsui, T. Matsuse, S. Kimura, and Y. Ouchi, 2000. Effect of ions on antibacterial activity of human beta defensin 2. Microbiol. Immunol. 44: 749-754
DOI
PUBMED
|
4 |
Tassi, A., S. Luca, and G. Anna. 2000. Amphipathic, Antimicrobial Peptides. Biopolymers 55: 4-30
DOI
ScienceOn
|
5 |
Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415: 389-395
DOI
ScienceOn
|
6 |
Lee, J. H., J. H. Kim, S. W. Hwang, W. J. Lee, H. K. Yoon, H. S. Lee, and S. S. Hong. 2000. High-level expression of antimicrobial peptide mediated by a fusion partner reinforcing formation of inclusion bodies. Biochem. Biophys. Res. Commun. 277: 575-580
DOI
ScienceOn
|
7 |
Brown, K. L. and R. E. Hancock. 2006. Cationic host defense (antimicrobial) peptides. Curr. Opin. Immunol. 18: 24-30
DOI
ScienceOn
|
8 |
Liu, D. and W. F. DeGrado. 2001. De novo design, synthesis, and characterization of antimicrobial beta-peptides. J. Am. Chem. Soc. 123: 7553-7559
DOI
ScienceOn
|
9 |
Lee, J. H., J. H. Kim, S. S. Hong, H. S. Lee, and S. C. Kim. 1999. Multimeric expression of the antimicrobial peptide buforin IT in Escherichia coli by fusion to a cysteine-rich acidic peptide. J. Microbiol. Biotechnol. 9: 303-310
|
10 |
Falla, T. J., D. N. Karunaratne, and R. E. Hancock. 1996. Mode of action of the antimicrobial peptide indolicidin. J. BioI. Chem. 271: 19298-19303
DOI
ScienceOn
|
11 |
Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor Laboratory Press, U.S.A
|
12 |
Ge, Y., D. L. MacDonald, K. J. Holroyd, C. Thornsberry, H. Wexler, and Z. Zasloff. 1999. In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob. Agents Chemother. 43: 782-788
PUBMED
|
13 |
Kliiver, E., S. Schulz-Maronde, S. Scheid, B. Meyer, W. G. Forssmann, and K. Adermann. 2005. Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity, Biochemistry 44: 9804-9816
DOI
ScienceOn
|
14 |
Tencza, S. B., J. P. Douglass, D. J. Creighton, R. C. Montelaro Jr., and T. A. Mietzner. 1997. Novel antimicrobial peptides derived from human immunodeficiency virus type 1 and other lentivirus transmembrane proteins. Antimicrob. Agents Chemother. 41: 2394-2398
PUBMED
|
15 |
Deslouches, B., S. M. Phadke, V. Lazarevic, M. Cascio, K. Islam, R. C. Montelaro, and T. A. Mietzner. 2005. De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity. Antimicrob. Agents Chemother. 49: 316-322
DOI
ScienceOn
|
16 |
Marr, A. K., W. J. Gooderham, and R. E. Hancock. 2006. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr. Opin. Pharmacol. 6: 468-472
DOI
ScienceOn
|
17 |
Minahk, C. J. and R. D. Morero. 2003. Inhibition of enterocin CRL35 antibiotic activity by mono- and divalent ions. Lett. Appl. Microbiol. 37: 374-379
DOI
ScienceOn
|